Involvement of heregulin-β2 in the acquisition of the hormone- independent phenotype of breast cancer cells

Cancer Research

Volumn 56, Issue 14, 1996, Pages 3350-3358

  Tang, Careen K ^a   Perez, Cynthia ^a   Grunt, Thomas ^a   Waibel, Caroline ^a   Cho, Cheryl ^a   Lupu, Ruth ^a,b  

^a GEORGETOWN UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; ESTROGEN RECEPTOR; NEU DIFFERENTIATION FACTOR; ONCOPROTEIN; RECEPTOR PROTEIN; CARRIER PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; GLYCOPROTEIN; GROWTH PROMOTOR; HEREGULIN BETA1; MESSENGER RNA; PROGESTERONE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; CONTROLLED STUDY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN FAMILY; PROTO ONCOGENE; SIGNAL TRANSDUCTION; BREAST TUMOR; CELL CULTURE; CELL DIVISION; FEMALE; GENE EXPRESSION REGULATION; GENETICS; PATHOPHYSIOLOGY; PHYSIOLOGY;

BREAST NEOPLASMS; CARRIER PROTEINS; CELL DIVISION; DNA, COMPLEMENTARY; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOPROTEINS; GROWTH SUBSTANCES; HUMANS; NEUREGULIN-1; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RNA, MESSENGER; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

EID: 0029666144     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Slamon, D. J., Clark, G. M , Wong, S. G., Levin, W. J., Ullrich, A , and McGuire W. L Human breast cancer: correlation of relapse and survival with amplification of the HER2/neu oncogene. Science (Washington DC), 235: 177-182, 1987.
2. Dougall, W. C., Quian, X , Peterson, N. C., Miller, M. J , Samanta, A., and Green, M. I. The neu oncogene: signal transduction pathways, transformation mechanisms and evolving therapies Oncogene (Basel), 9: 2109-2123, 1994.
3. Slamon, D. J., Godolphin, W., Jones, L. A., Holt, J A , Wong, S G , Keith, D. E., Levin, W J., Stuart, S. G., Udove, J , and Ullrich, A. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science (Washington DC), 244: 707-712, 1989
4. Harris, J., Lippman, M., Veronesi, U., and Willett, W Breast cancer. N. Engl. J Med., 327: 473-481, 1992
5. Xu, Y. H , Ishii, S , Clark, A. J , Sullivan, M., Wilsm, R K , Ma, D. P. Roe, B. A., Merlino, G T. and Pastan, I. Human epidermal growth factor receptor cDNA is homologous to a variety of RNAse overproduced in A431 carcinoma cells. Nature (Lond.), 309: 806-810, 1984
6. r tumour antigen. Nature (Lond.), 312: 513-516, 1984
7. Schechter, A. L., Hung, M C , Vaidyanathan, L , Weinberg, R A , Yang-Feng, T. L., Francke, U., Ullrich, A., and Coussens, L The neu gene: an erbB-homologous gene distinct from and unlinked to the gene encoding the EGF receptor. Science (Washington DC), 229: 976-987, 1985
8. Coussens, L., Yang-Feng, T L., Liao, Y. C., Chen, E., Gray, A., McGrath, J., Seeburg, P. H , Libermann, T A , Schlesinger, J., Francke, U , and Toyoshima, K Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene. Science (Washington DC), 230 1132-1139, 1985.
9. Yamamoto, T , Ikawa, S , Akijama, T , Semba, K , Numura, N , Miyajima, N., and Saito, T Similarity of protein encoded by the human c-erbB-2 gene to epidermal growth factor receptor Nature (Lond.), 319, 230-234, 1986
10. Bargmann C. I., Hung M C , and Weinberg, R. A The neu oncogene encodes an epidermal growth factor receptor-related protein Nature (Lond), 319: 226-230, 1986.
11. Stern, D F , Heffernan, P A , and Weinberg RA p185, a product of the neu proto-oncogene, is a receptor like protein associated with tyrosine kinase activity. Mol Cell Biol 6: 1729-1740, 1986.
12. Kraus, M H , Issing, W , Miki, T , Popeson, N C , and Aaronson, S. A. Isolation and characterization of ERBB3, a third member of the ERBB/epidermal growth factor receptor family: evidence for overexpression in an subset of human mammary tumors Proc Natl. Acad. Sci. USA, 86: 9193-9197, 1989.
13. Plowman, G. D., Whitney, G. S , Neubauer, M. G., Green, J. M., McDonald, V. L., Todaro, G. J , and Shoyab, M. Molecular cloning and expression of an additional epidermal growth factor receptor related gene Proc. Natl Acad. Sci USA, 87: 4905-4909, 1990.
14. erbB4, a forth member of the epidermal growth factor receptor family. Proc Natl Acad. Sci. USA. 90: 1746-1750, 1993.
15. Allred, D. C., Clark, G. M., Molina, R , et al. Overexpression of HER-2/neu and its relationship with other prognostic factors change during the progression of in situ to invasive breast cancer. Hum. Pathol., 23, 974-979, 1992.
16. Van de Vijer, M J., Johannes, L. P., Wolter, J. M., et al Neu-protein overexpression in breast cancer Association with comedo-type ductal carcinoma in situ and limited prognostic value in stage II breast cancer. New Engl. J. Med., 319: 1239-1245, 1988.
17. De Potter, C. R. Beghin, C., Makar, A. P., et al. The neu oncogene protein as a predictive factor for hematogenous metastases in breast cancer patients Int. J. Cancer, 45 55-58, 1990.
18. Tikannen, S., Helm, H , Isola, J., and Joensuu, H. Prognostic significance of HER-2 oncoprotein expression in breast cancer: a 30 year follow-up. J Clin. Oncol., 10: 1044-1048, 1992.
19. Gusterson, B. A., Gelber, R. D , Goldhirsch, K. N., Price, K N., Save-Soderbough, J., Anbazhagan, R., Styles, J., Rudenstam, C. M., Golouh, R., and Reed, R. Prognostic importance of c-erbB-2 expression in breast cancer. J. Clin. Oncol., 10 1049-1056, 1992.
20. Paik, S , Kazan, R., Fisher, E. R., Sass, R. E., Fisher, B., Redmond, C., Schlessinger, J , Lippman, M E., and King, C. R. Pathologic findings from the national surgical adjuvant breast and bowel project: prognostic significance of erbB-2 protein overexpression in primary breast cancer J. Clin. Oncol., 8: 103-112, 1990.
21. Lacroix, H , Iglehart, J. D , Skinner, M. A., and Kraus, M. H. Overexpression of erbB-2 or EGF receptor proteins present in early stage mammary carcinoma is detected simultaneously in matched primary tumors and regional metastasis. Oncogene (Basel), 4: 145-151, 1989
22. Huang, S. S., and Huang, J. S. Purification and characterization of the neu/erbB2 ligand growth factor from bovine kidney. J. Biol Chem , 267: 11508-11512, 1992.
23. Peles, E., Bacus, S. S., Koski, R. A., Lu, H. S , Wen, D , Ogden, S. G., Levy, R B., and Yarden, Y Isolation of the Neu/HER-2 stimulatory ligand: a 44 kd glycoprotein that induces differentiation of mammary tumor cells. Cell, 69: 205-216, 1992.
24. erbB2. Science (Washington DC), 256: 1206-1210, 1992
25. erb-2. Science (Washington DC), 249 1552-1555, 1990.
26. Lupu, R , Dickson, R. B., and Lippman, M. E The role of erbB-2 and its ligands in the growth control of malignant breast epithelium. J Steroid Biochem. Mol. Biol., 43: 229-236, 1992.
27. Lupu, R , Colomer, R., Kannan, B , and Lippman, M. E. Characterization of a growth factor that binds exclusively to the erbB-2 receptor and induces cellular response Proc. Natl. Acad. Sci. USA, 89: 2287-2291, 1992
28. Marchionni, M. A., Goodearl, A. D. J., Chen, M. S., Bermingham-McDonogh, O., Kirk, C , Hendricks, M., Danehy, F , Misumi, D., Sudhalter, J , and Kobayashik, K. Glial growth factors are alternatively spliced erbB2 ligands expressed in the nervous system. Nature (Lond.), 362: 312-318, 1993.
29. Falls, D. L., Rosen, K. M., Corfas, G , Lane, W S., and Fischbach, G D ARIA, a protein that stimulates acetylcholine receptor synthesis, is a member of the neu ligand family. Cell. 72: 801-815, 1993
30. erbB-4. Nature (Lond), 366: 473-475, 1993.
31. Peles, E., Ben-Levy, R , Tzahar, E., Liu, N., Wen, D., and Yarden, Y Cell type specific interaction of neu differentiation factor (NDF/HRG) with Neu/Her-2 suggests complex ligand-receptor relationships. EMBO J , 12: 961-971, 1993.
32. Carraway, K. L , III, Sliwkowski, M. X., Akita, R. W., Platko, J. V., Guy, P M , Nuijens, A , Diamonti, A J., Vandlen, R. L., Cantley, L. C., and Cerione, R. A The erbB-3 gene product is a receptor for HRG J. Biol Chem., 269: 14303-14306, 1994
33. Sliwkowski, M. X., Schaefer, G., Akita, R. W , Lofgren, J. A., Fitzpatrick, V. D , Nuijens, A., Fendly, B. M., Cerione, R. A., Vandlen, R. L , and Carraway, K L , III Coexpression of erbB-2 and erbB-3 proteins reconstitute a high affinity receptor for HRG. J. Biol Chem., 269: 14661-14665, 1994
34. Carraway K L., III, and Cantley, L. C. A neu acquaintance for erbB-3 and erbB-4: a role for receptor heterodimerization in growth signaling. Cell, 78: 5-8, 1994
35. Godolphin, W., Elwood, J. M., and Spinelh, J. J. Estrogen receptor quantitation and staging as complimentary prognostic indicators in breast cancer. Int. J. Cancer, 28: 677-683, 1981.
36. McGuire, W L., Clarke, G. M., Dressier, L. G , and Owens, M. A. Role of steroid hormone receptors as prognostic factors in primary breast cancer. J. Natl. Cancer Inst Monogr., 1: 19-24, 1986.
37. Russell, K. S., and Hung, M. C Transcriptional repression of the neu proto-oncogene by estrogen stimulated estrogen receptor. Cancer Res , 52: 6624-6629, 1992.
38. Grunt, T., Saceda, M., Martin, M. B , Lupu, R., Dittrich, E., Krupitza, G., Harant, H., Huber, H., and Dittrich, C. Bidirectional interactions between the estrogen receptor and the c-erbB-2 signaling pathways: HRG inhibits estrogenic effects in breast cancer cells. Int. J. Cancer. 63: 560-567, 1995.
39. Lupu, R., and Lippman, M. E. The role of erbB-2 signal transduction pathways in human breast cancer. Breast Cancer Res. Treat., 27: 83-93, 1993.
40. Lippman, M. E. Endocrine responsive cancers of man. In R. H. Williams (ed), Textbook of Endocrinology, pp. 1309-1326, 1985
41. Lemoine, N. R , Barnes, D. M., Hollywood, D. P., Hughes, C M , Smith, P., Cublin, E., Prigent, S. A., Gullick, W. J., and Hurst, H. C. Expression of the erbB-3 gene product in breast cancer Br. J. Cancer, 66: 1116-1121, 1992.
42. Earp, S. H., Dawson, T. L., Li, X., and Yu, H. Heterodimerization and functional interaction between EGF receptor family member a new signaling paradigm with implications for breast cancer research. Breast Cancer Res. Treat., 35: 115-132, 1995.
43. Dati, C., Antoniotti, S., Taverna, D , Perroteau, I , and De Bortoli, M. Inhibition of c-erbB-2 oncogene expression by estrogens in human breast cancer cells Oncogene (Basel), 5: 1001-1006, 1990
44. Warri, A. M., Laine, A M , Majasuo, K. E., Alitalo, K. K., and Harkonen, P. L. Estrogen suppression of erbB-2 expression is associated with increased growth rate of ZR-75-1 human breast cancer cells in vitro and in nude mice. Int J. Cancer, 49: 616-623, 1991.
45. Adnane, J., Gaudray, P , Simon, M P., Simony-Lafontaine, J , Jeanteur, P., and Theillet, C. Proto-oncogene amplification and human breast tumor phenotype. Oncogene (Basel), 4: 1389-1395, 1989.
46. Read, L. D., Keith, D., Slamon, D., and Katzellenbogen, B. S. Hormonal modulation of HER-2/neu proto-oncogene messenger ribonucleic acid and p185 protein expression in human breast cancer cell lines. Cancer Res., 50: 3947-3951, 1990.
47. Lippman, M. E , and Dickson, R B. Mechanisms of growth control in normal and malignant breast epithelium. Recent Progr. Horm. Res., 45: 383-493, 1989.
48. Borras, M., Hardy. L , Lempereur, F., El Khissiin, A. H., Legroos, N., Gol-Winkler, R., and Leclercq, G. Estradiol-induced down-regulation of estrogen receptor. Effect of various modulators of protein synthesis and expression. J Steroid Biochem Mol Biol., 48: 325-336, 1994.
49. Pietras, R J., Arboleda, J., Reese, D. M., Wongvipat, N., Pegram, M. D., Ramos, L , German, C. M., Parker, M. G , Sliwkowski, M. X., and Slamon, D. J. HER-2 tyrosine kinase pathway target estrogen receptor and promotes hormone-independent growth in human breast cancer cells Oncogene (Basel), 10: 2435-2446, 1995.